@article{ad0568c3bfa74180bebc27d3fa6dfd91,
title = "Ibrutinib is an effective treatment for B-cell prolymphocytic leukaemia",
keywords = "cytogenetics, ibrutinib, prolymphocytic leukaemia",
author = "Gordon, {Max J.} and Raess, {Philipp W.} and Kathleen Young and Spurgeon, {Stephen E.F.} and Danilov, {Alexey V.}",
note = "Funding Information: AVD is supported by the Lymphoma Research Foundation Clinical Investigator Career Development Award. SES receives funding from SWOG/HOPE Foundation and the Leukemia and Lymphoma Society.",
year = "2017",
month = nov,
doi = "10.1111/bjh.14224",
language = "English (US)",
volume = "179",
pages = "501--503",
journal = "British Journal of Haematology",
issn = "0007-1048",
publisher = "Wiley-Blackwell",
number = "3",
}